*	OR T6 T7
*	OR T4 T5
R1	Has_qualifier Arg1:T4 Arg2:T6	
R2	AND Arg1:T3 Arg2:T4	
R3	Has_qualifier Arg1:T2 Arg2:T11	
R4	Subsumes Arg1:T12 Arg2:T13	
*	OR T14 T15
*	OR T17 T18 T19 T16
*	OR T21 T22
R5	Has_temporal Arg1:T21 Arg2:T23	
R6	Has_qualifier Arg1:T25 Arg2:T26	
R7	Has_qualifier Arg1:T29 Arg2:T30	
*	OR T28 T29
R8	AND Arg1:T27 Arg2:T28	
R9	AND Arg1:T32 Arg2:T33	
*	OR T34 T35
R10	Has_qualifier Arg1:T37 Arg2:T38	
R11	Has_negation Arg1:T40 Arg2:T39	
*	OR T43 T44 T45
R12	Has_value Arg1:T42 Arg2:T43	
R13	AND Arg1:T41 Arg2:T42	
R14	Has_qualifier Arg1:T56 Arg2:T57	
*	OR T51 T52
R15	Has_qualifier Arg1:T51 Arg2:T50	
R16	Has_value Arg1:T49 Arg2:T51	
*	OR T49 T53 T55 T56
R17	Has_value Arg1:T64 Arg2:T65	
R18	AND Arg1:T63 Arg2:T64	
R19	AND Arg1:T66 Arg2:T67	
R20	Has_value Arg1:T67 Arg2:T68	
*	OR T63 T66
*	OR T71 T72
*	OR T69 T70
R21	Has_qualifier Arg1:T69 Arg2:T71	
R22	AND Arg1:T75 Arg2:T76	
R23	Has_value Arg1:T76 Arg2:T77	
*	OR T79 T80
R24	Has_qualifier Arg1:T83 Arg2:T84	
R25	Has_value Arg1:T88 Arg2:T89	
T1	Condition 31 45	atrial flutter
T3	Condition 115 117	AF
T4	Drug 138 152	antiarrhythmic
T5	Drug 156 163	sotalol
T6	Qualifier 123 130	class I
T7	Qualifier 123 128;134 137	class III
T9	Non-query-able 164 322	with the intention to prevent an AF recurrence. Patients pretreated with above AAD at maximum 48 hours with the intention to convert an AF episode are allowed
T2	Procedure 355 370	atrial ablation
T11	Qualifier 350 354	left
T12	Procedure 398 413	cardiac surgery
T13	Device 420 437	prosthetic valves
T14	Device 452 471	permanent pacemaker
T15	Device 475 496	defibrillator implant
T16	Condition 523 541	3° degree AV-block
T17	Condition 511 521;533 541	2° type II AV-block
T18	Condition 550 575	right bundle branch block
T19	Condition 545 549;556 575	left bundle branch block
T20	Condition 598 622	unstable angina pectoris
T21	Condition 657 678	myocardial infarction
T22	Procedure 682 707	percutaneous intervention
T23	Temporal 719 736	last three months
T25	Condition 763 779	carotid stenosis
T26	Qualifier 751 762	symptomatic
T27	Condition 794 831	chronic obstructive pulmonary disease
T28	Condition 846 868	pulmonary hypertension
T29	Condition 906 918	lung disease
T30	Qualifier 894 905	significant
T32	Condition 937 953	contraindication
T33	Drug 958 978	oral anticoagulation
T34	Condition 1017 1042	transient ischemic attack
T35	Condition 1046 1052	stroke
T36	Condition 1073 1095	intra-cardiac thrombus
T37	Condition 1136 1159	congenital heart defect
T38	Qualifier 1124 1135	significant
T39	Negation 1178 1184	except
T40	Condition 1189 1209	patent foramen ovale
T41	Condition 1253 1277	congestive heart failure
T42	Measurement 1279 1289	NYHA class
T43	Value 1290 1292	II
T44	Value 1294 1297	III
T45	Value 1301 1303	IV
T46	Condition 1308 1320	sinus rhythm
T48	Condition 1335 1362	hypertrophic cardiomyopathy
T49	Measurement 1400 1411	QT interval
T50	Qualifier 1377 1385	abnormal
T51	Value 1386 1390	long
T52	Value 1394 1399	short
T53	Condition 1422 1438	Brugada syndrome
T54	Condition 1446 1476	inheriting ion channel disease
T55	Observation 1446 1490	inheriting ion channel disease on the family
T56	Condition 1507 1534	right ventricular dysplasia
T57	Qualifier 1492 1506	arrhythmogenic
T59	Condition 1549 1560	sarcoidosis
T60	Device 1575 1595	pulmonary vein stent
T61	Condition 1610 1616	myxoma
T62	Non-query-able 1618 1670	Exclusion criteria based on laboratory abnormalities
T63	Condition 1684 1698	thrombocytosis
T64	Measurement 1700 1714	platelet count
T65	Value 1715 1729	> 600,000 / µl
T66	Condition 1734 1750	thrombocytopenia
T67	Measurement 1752 1766	platelet count
T68	Value 1767 1780	<100,000 / µl
T69	Condition 1826 1841	hyperthyroidism
T70	Condition 1845 1859	hypothyroidism
T71	Qualifier 1800 1809	untreated
T72	Qualifier 1813 1825	uncontrolled
T75	Condition 1874 1891	renal dysfunction
T76	Measurement 1897 1923	glomerular filtration rate
T77	Value 1924 1937	< 60 ml / min
T78	Condition 1958 1975	cryoglobulinaemia
T79	Condition 2049 2064	hyperthyroidism
T80	Condition 2069 2079	alcoholism
T81	Pregnancy_considerations 2082 2396	Subject is a pregnant woman or woman of childbearing potential not on adequate birth control: only woman with a highly effective method of contraception [oral contraception or intra-uterine device] (who must have a negative pregnancy test within 1 week of the start of the therapy) or sterile woman can be enrolled
T82	Pregnancy_considerations 2399 2431	Subject is a breastfeeding woman
T83	Condition 2456 2474	systemic infection
T84	Qualifier 2449 2455	active
T85	Post-eligibility 2477 2609	Subject is employed by Medtronic or by the department of any of the investigators or is a close relative of any of the investigators
T86	Post-eligibility 2612 2890	Subject is unwilling or unable to comply fully with study procedures and follow-up due to any disease condition, which can raise doubt about compliance and influencing the study outcome especially any kind of cancer, severe bleeding in history or a suspected pro-coagulant state
T87	Post-eligibility 2894 3054	egal incapacity or evidence that a subject cannot understand the purpose and risks of the study or inability to comply fully with study procedures and follow up
T88	Observation 3071 3086	life expectancy
T89	Value 3090 3098	= 1 year
T90	Competing_trial 3101 3365	Subject is currently enrolled or planning to participate in a potentially confounding drug or device trial during the course of this study. Co-enrollment in concurrent trials is only allowed when documented pre-approval is obtained from the Medtronic study manager
